What is Aumet?
Aumet operates as a B2B digital platform designed to connect pharmaceutical manufacturers, distributors, pharmacies, and healthcare providers. Its AI-driven healthcare marketplace and procurement system are engineered to streamline ordering, optimize supply chain coordination, and manage inventory across the medical ecosystem. By facilitating data exchange and providing real-time decision support, Aumet aims to improve medicine availability, reduce operational inefficiencies, and increase transparency within healthcare supply chains. The company's focus on digitizing pharmaceutical procurement and building scalable infrastructure positions it as a key player in healthcare commerce across various regions.
How much funding has Aumet raised?
Aumet has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2026): $12M with participation from Emkan Capital, Qatar Development Bank, Shorooq Partners, and Right Side Capital Management
Key Investors in Aumet
Emkan Capital
Emkan Capital is an investment firm focused on mentoring and investing in early-stage technology companies in the MENA region, providing growth capital and access to global co-investors.
Qatar Development Bank
Qatar Development Bank (QDB) is dedicated to supporting the growth and diversification of businesses in Qatar, offering services to entrepreneurs, SMEs, and startups to foster a thriving business environment.
Shorooq Partners
Shorooq is a leading alternative investments manager in the MENA region, focusing on venture capital and private credit, partnering with founders to fuel growth across diverse sectors.
What's next for Aumet?
The substantial enterprise-level funding and recent strategic investment signal a strong growth trajectory for Aumet. This capital infusion is anticipated to fuel further development of its AI capabilities, expand its market reach, and enhance its procurement system. Aumet is poised to further solidify its position as a leader in healthcare technology by driving digital transformation and efficiency within the pharmaceutical supply chain, potentially leading to broader adoption of its innovative solutions across the global healthcare sector.
See full Aumet company page
